In 2003, the International Human Genome Sequencing Consortium completed the first whole genome sequencing of human DNA after years of worldwide collaboration and billions of dollars of investment. Many human genomes have since been sequenced, the analysis of which has lead to many important discoveries. The factors that contribute to disease and if they affect different populations in different ways can be discovered by determining the correlations between people’s lifestyle, family history, environment and genomic data. There is now widespread motivation to sequence the genomes of hundreds of thousands, even millions, of individuals to learn even more. The global market for genomics is expected to reach USD 23.88b by 2022 (up from $14.71b in 2017), growing at an estimated CAGR of 10.2% from 2017 to 2020 due to increased investment in diagnostic services.